NORRIS PERNE & FRENCH LLP/MI - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORRIS PERNE & FRENCH LLP/MI ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$343,527
-12.2%
3,373
-13.0%
0.03%
-9.1%
Q2 2023$391,081
+7.8%
3,876
-1.7%
0.03%0.0%
Q1 2023$362,806
+1.6%
3,944
+0.2%
0.03%
-5.7%
Q4 2022$356,941
+19.4%
3,9350.0%0.04%
+12.9%
Q3 2022$299,000
-10.2%
3,9350.0%0.03%
-3.1%
Q2 2022$333,000
-14.2%
3,935
-10.9%
0.03%
+3.2%
Q1 2022$388,000
-25.5%
4,417
-25.8%
0.03%
-22.5%
Q4 2021$521,000
-49.6%
5,954
-52.9%
0.04%
-55.1%
Q3 2021$1,034,000
-11.3%
12,648
-1.0%
0.09%
-11.0%
Q2 2021$1,166,000
-93.2%
12,778
-93.6%
0.10%
-93.7%
Q1 2021$17,065,000
-11.0%
199,637
-1.6%
1.58%
-12.3%
Q4 2020$19,164,000
+25.6%
202,945
+15.6%
1.81%
+8.9%
Q3 2020$15,264,000
+1.8%
175,534
+2.2%
1.66%
-9.2%
Q2 2020$14,999,000
+9.5%
171,730
+3.4%
1.82%
-11.2%
Q1 2020$13,698,000
+8.4%
166,142
+24.6%
2.06%
+36.3%
Q4 2019$12,631,000
+8.5%
133,392
-0.5%
1.51%
+3.9%
Q3 2019$11,645,000
-5.0%
134,000
-0.2%
1.45%
-6.3%
Q2 2019$12,264,000
-5.6%
134,308
-0.6%
1.55%
-9.5%
Q1 2019$12,994,000
+14.7%
135,157
+2.4%
1.71%
-3.4%
Q4 2018$11,329,000
+1.4%
132,022
+1.8%
1.77%
+21.1%
Q3 2018$11,172,000
+18.8%
129,664
+4.1%
1.46%
+6.6%
Q2 2018$9,408,000
-4.5%
124,539
+2.2%
1.37%
-4.3%
Q1 2018$9,850,000
-3.4%
121,829
+0.3%
1.43%
-3.4%
Q4 2017$10,198,000
-2.0%
121,461
+0.2%
1.48%
-8.5%
Q3 2017$10,402,000
+4.9%
121,159
+2.0%
1.62%
-2.6%
Q2 2017$9,917,000
+12.3%
118,803
-0.1%
1.66%
+0.8%
Q1 2017$8,833,000
+75.3%
118,934
+72.0%
1.65%
+66.2%
Q4 2016$5,038,000
-15.4%
69,161
-8.2%
0.99%
-19.9%
Q3 2016$5,952,000
+12.0%
75,379
+17.0%
1.24%
+8.2%
Q2 2016$5,315,000
+14.8%
64,416
+0.8%
1.14%
+19.4%
Q1 2016$4,629,000
-0.0%
63,904
+18.8%
0.96%
-1.1%
Q4 2015$4,630,000
+149.2%
53,807
+166.2%
0.97%
+118.0%
Q3 2015$1,858,000
-18.2%
20,212
-12.5%
0.44%
+2.5%
Q2 2015$2,271,000
+0.4%
23,092
+0.7%
0.43%
+3.6%
Q1 2015$2,261,000
+6.9%
22,926
+0.4%
0.42%
+8.5%
Q4 2014$2,116,000
+13.2%
22,842
+15.0%
0.39%
+6.6%
Q3 2014$1,869,000
+6.1%
19,860
+2.1%
0.36%
+9.0%
Q2 2014$1,761,000
+5.5%
19,456
-0.9%
0.33%
+1.2%
Q1 2014$1,669,000
+43.9%
19,635
+36.0%
0.33%
+50.5%
Q4 2013$1,160,000
+10.0%
14,434
+4.9%
0.22%
+0.5%
Q3 2013$1,055,000
+7.5%
13,759
-0.9%
0.22%
+3.3%
Q2 2013$981,00013,8840.21%
Other shareholders
NOVARTIS A G shareholders Q1 2023
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders